ARX201 + ARX201 + ARX201
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Growth Hormone Deficiency
Conditions
Growth Hormone Deficiency
Trial Timeline
Jul 1, 2008 → Oct 1, 2009
NCT ID
NCT00778518About ARX201 + ARX201 + ARX201
ARX201 + ARX201 + ARX201 is a phase 2 stage product being developed by Merck for Growth Hormone Deficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT00778518. Target conditions include Growth Hormone Deficiency.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00778518 | Phase 2 | Completed |
Competing Products
20 competing products in Growth Hormone Deficiency